Strassburg CP: Pharmacogenetics of Gilbert's syndrome. Pharmacogenomics. 2008, 9: 703-715. 10.2217/14622416.9.6.703.
Article
CAS
PubMed
Google Scholar
Perera MA, Innocenti F, Ratain MJ: Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: Are we there yet?. Pharmacotherapy. 2008, 28: 755-768. 10.1592/phco.28.6.755.
Article
CAS
PubMed
Google Scholar
Kiang TK, Ensom MH, Chang TK: UDP-glucuronosyl-transferases and clinical drug-drug interactions. Pharmacol Ther. 2005, 106: 97-132. 10.1016/j.pharmthera.2004.10.013.
Article
CAS
PubMed
Google Scholar
Lankisch TO, Behrens G, Ehmer U, Möbius U, et al: Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy -- An extended haplotype of genetic variants increases risk in indinavir treatment. J Hepatol. 2009, 50: 1010-1018. 10.1016/j.jhep.2008.12.030.
Article
CAS
PubMed
Google Scholar
Zhang D, Zhang D, Cui D, Gambardella J, et al: Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos. 2007, 35: 2270-2280. 10.1124/dmd.107.017806.
Article
CAS
PubMed
Google Scholar
Innocenti F, Iyer L, Ratain MJ: Pharmacogenetics of anticancer agents: Lessons from amonafide and irinotecan. Drug Metab Dispos. 2001, 29: 596-600.
CAS
PubMed
Google Scholar
Duguay Y, McGrath M, Lépine J, Gagné JF, et al: The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res. 2004, 64: 1202-1207. 10.1158/0008-5472.CAN-03-3295.
Article
CAS
PubMed
Google Scholar
Guillemette C, Millikan RC, Newman B, Housman DE, et al: Genetic polymorphisms in uridine diphospho-glucuronosyltrans-ferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000, 60: 950-956.
CAS
PubMed
Google Scholar
Sparks R, Ulrich CM, Bigler J, Tworoger SS, et al: UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res. 2004, 6: R488-R498. 10.1186/bcr818.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jemnitz K, Lengyel G, Vereczkey L: In vitro induction of bilirubin conjugation in primary rat hepatocyte culture. Biochem Biophys Res Commun. 2002, 291: 29-33. 10.1006/bbrc.2002.6400.
Article
CAS
PubMed
Google Scholar
Wenning LA, Hanley WD, Brainard DM, Petry AS, et al: Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir. Antimicrob Agents Chemother. 2009, 53: 2852-2856. 10.1128/AAC.01468-08.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brierley CH, Senafi SB, Clarke D, Hsu MH, et al: Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Adv Enzyme Regul. 1996, 36: 85-97.
Article
CAS
PubMed
Google Scholar
Ramírez J, Komoroski BJ, Mirkov S, Graber AY, et al: Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenet Genomics. 2006, 16: 79-86. 10.1097/01.fpc.0000182784.77630.48.
Article
PubMed
Google Scholar
Innocenti F, Undevia SD, Iyer L, Chen PX, et al: Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol. 2004, 22: 1382-1388. 10.1200/JCO.2004.07.173.
Article
CAS
PubMed
Google Scholar
Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, et al: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst. 2007, 99: 1290-1295. 10.1093/jnci/djm115.
Article
CAS
PubMed
Google Scholar
Cecchin E, Innocenti F, D'Andrea M, Corona G, et al: Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. J Clin Oncol. 2009, 27: 2457-2465. 10.1200/JCO.2008.19.0314.
Article
CAS
PubMed
Google Scholar
Corona G, Vaccher E, Sandron S, et al: Lopinavirritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma. Clin Pharm Ther. 2008, 83: 601-606. 10.1038/sj.clpt.6100330.
Article
CAS
Google Scholar
Trontelj J, Marc J, Zavratnik A, Bogataj M, et al: Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol. 2009, 67: 437-444. 10.1111/j.1365-2125.2009.03363.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wenning LA, Petry AS, Kost JT, Jin B, et al: Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms. Clin Pharmacol Ther. 2009, 85: 623-627. 10.1038/clpt.2009.12.
Article
CAS
PubMed
Google Scholar
Placeres Alsina MM, Tuset Creus M, Miró JM: Pharmacokinetics and interactions of raltegravir. Enferm Infecc Microbiol Clin. 2008, 26: 23-28.
Article
PubMed
Google Scholar
Rotger M, Taffé P, Bleiber G, Gunthard HF, et al: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis. 2005, 192: 1381-1386. 10.1086/466531.
Article
CAS
PubMed
Google Scholar
Lankisch TO, Moebius U, Wehmeier M, Behrens G, et al: Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyl-transferase haplotype. Hepatology. 2006, 44: 1324-1332. 10.1002/hep.21361.
Article
CAS
PubMed
Google Scholar
Anderson PL, Aquilante CL, Gardner EM, Predhomme J, et al: Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J Antimicrob Chemother. 2009, 64: 1071-1079. 10.1093/jac/dkp317.
Article
PubMed Central
CAS
PubMed
Google Scholar
Anderson PL, Lamba J, Aquilante CL, Schuetz E, et al: Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study. J Acquir Immune Defic Syndr. 2006, 42: 441-449. 10.1097/01.qai.0000225013.53568.69.
Article
CAS
PubMed
Google Scholar
Meza-Junco J, Chu QS, Christensen O, Rajagopalan P, et al: UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. Cancer Chemother Pharmacol. 2009, 65: 1-4. 10.1007/s00280-009-1096-4.
Article
PubMed
Google Scholar
Mross K, Steinbild S, Baas F, Gmehling D, et al: Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib. Eur J Cancer. 2007, 43: 55-63. 10.1016/j.ejca.2006.08.032.
Article
CAS
PubMed
Google Scholar
Wen Z, Tallman MN, Ali SY, Smith PC: UDP-glucuro-nosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: Structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Drug Metab Dispos. 2007, 35: 371-380.
Article
CAS
PubMed
Google Scholar
Biondi ML, Turri O, Dilillo D, Stival G, et al: Contribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian population. Clin Chem. 1999, 45: 897-898.
CAS
PubMed
Google Scholar
Te Morsche RH, Zusterzeel PL, Raijmakers MT, Roes EM, et al: Polymorphism in the promoter region of the bilirubin UDP-glucuronosyltransferase (Gilbert's syndrome) in healthy Dutch subjects. Hepatology. 2001, 33: 765-10.1053/jhep.2001.0103303le03.
Article
CAS
PubMed
Google Scholar
Fernández Salazar JM, Remacha Sevilla A, del Río Conde E, Baiget Bastús M: Distribution of the A(TA)7TAA genotype associated with Gilbert syndrome in the Spanish population. Med Clin(Barc). 2000, 115: 540-541.
Article
PubMed
Google Scholar
Burchell B, Hume R: Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol. 1999, 14: 960-966. 10.1046/j.1440-1746.1999.01984.x.
Article
CAS
PubMed
Google Scholar
Fertrin KY, Gonc¸alves MA, Saad ST, Costa FF: Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet. 2002, 118: 117-119.
Article
Google Scholar
Premawardhena A, Fisher CA, Liu YT, Verma IC, et al: The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis. 2003, 31: 98-101. 10.1016/S1079-9796(03)00071-8.
Article
CAS
PubMed
Google Scholar
Jada SR, Lim R, Wong CI, Shu X, et al: Pole of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C > A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci. 2007, 98: 1461-1467. 10.1111/j.1349-7006.2007.00541.x.
Article
CAS
PubMed
Google Scholar
Zhang A, Xing Q, Qin S, Du J, et al: Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations. Pharmacogenomics J. 2007, 7: 333-338. 10.1038/sj.tpj.6500424.
Article
CAS
PubMed
Google Scholar
Boyd MA, Srasuebkul P, Ruxrungtham K, Mackenzie PI, et al: Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Pharmacogenet Genomics. 2006, 16: 321-329. 10.1097/01.fpc.0000197465.14340.d4.
Article
CAS
PubMed
Google Scholar
Takeuchi K, Kobayashi Y, Tamaki S, et al: Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol. 2004, 19: 1023-1028. 10.1111/j.1440-1746.2004.03370.x.
Article
CAS
PubMed
Google Scholar
Sekine I, Yamamoto N, Nishio K, Saijo N: Emerging ethnic differences in lung cancer therapy. Br J Cancer. 2008, 99: 1757-1762. 10.1038/sj.bjc.6604721.
Article
PubMed Central
CAS
PubMed
Google Scholar
Beutler E, Gelbart T, Demina A: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad SciUSA. 1998, 95: 8170-8174. 10.1073/pnas.95.14.8170.
Article
CAS
Google Scholar
Brites D, Fernandes A, Falcão AS, Gordo AC, et al: Biological risks for neurological abnormalities associated with hyperbilirubinemia. J Perinatol. 2009, 29 (Suppl 1): S8-13.
Article
CAS
PubMed
Google Scholar
van der Bol JM, Mathijssen RH, Loos WJ, Friberg LE, et al: Cigarette smoking and irinotecan treatment: Pharmacokinetic interaction and effects on neutropenia. J Clin Oncol. 2007, 25: 2719-2726. 10.1200/JCO.2006.09.6115.
Article
CAS
PubMed
Google Scholar
Peterson S, Bigler J, Horner NK, Potter JD, et al: Cruciferae interact with the UGT1A1*28 polymorphism to determine serum bilirubin levels in humans. J Nutr. 2005, 135: 1051-1055.
CAS
PubMed
Google Scholar
Court MH: Interindividual variability in hepatic drug glucuronidation: Studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev. 2010, 42: 202-217.
Article
Google Scholar
Saracino MR, Bigler J, Schwarz Y, Chang JL, et al: Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism. J Nutr. 2009, 139: 555-560. 10.3945/jn.108.097279.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chang JL, Bigler J, Schwarz Y, Li SS, et al: UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial. J Nutr. 2007, 137: 890-897.
CAS
PubMed
Google Scholar
Cheng TO: Green tea may inhibit warfarin. Int J Cardiol. 2007, 115: 236-10.1016/j.ijcard.2006.04.003.
Article
PubMed
Google Scholar
Cheng TO: Not only green tea but also green leafy vegetables inhibit warfarin. Int J Cardiol. 2008, 125: 101-10.1016/j.ijcard.2006.12.002.
Article
PubMed
Google Scholar
Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, et al: Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009, 86: 28-31. 10.1038/clpt.2009.30.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gold HT, Hall MJ, Blinder V, Schackman BR: Cost-effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer. Cancer. 2009, 115: 3858-3867. 10.1002/cncr.24428.
Article
PubMed Central
CAS
PubMed
Google Scholar
Obradovic M, Mrhar A, Kos M: Cost-effectiveness of UGT1A1 genotyping in second line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer. Pharmacogenomics. 2008, 9: 539-549. 10.2217/14622416.9.5.539.
Article
CAS
PubMed
Google Scholar